225 related articles for article (PubMed ID: 33377441)
21. Frailty modifies the effect of polypharmacy and multimorbidity on the risk of death among nursing home residents: Results from the SHELTER study.
Zazzara MB; Villani ER; Palmer K; Fialova D; Corsonello A; Soraci L; Fusco D; Cipriani MC; Denkinger M; Onder G; Liperoti R
Front Med (Lausanne); 2023; 10():1091246. PubMed ID: 36817789
[TBL] [Abstract][Full Text] [Related]
22. Post-fracture pneumonia risk and association with health and survival outcomes for adults with cerebral palsy: A retrospective cohort study.
Whitney DG; Xu T; Berri M
Bone; 2022 Jun; 159():116390. PubMed ID: 35307581
[TBL] [Abstract][Full Text] [Related]
23. Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults.
Mielke N; Barghouth MH; Fietz AK; Villain C; Bothe T; Ebert N; Schaeffner E
BMC Geriatr; 2024 Apr; 24(1):335. PubMed ID: 38609867
[TBL] [Abstract][Full Text] [Related]
24. Risk of Depression and Anxiety in Adults With Cerebral Palsy.
Smith KJ; Peterson MD; O'Connell NE; Victor C; Liverani S; Anokye N; Ryan JM
JAMA Neurol; 2019 Mar; 76(3):294-300. PubMed ID: 30592485
[TBL] [Abstract][Full Text] [Related]
25. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.
Singh JA; Cleveland JD
BMC Nephrol; 2019 Mar; 20(1):93. PubMed ID: 30876398
[TBL] [Abstract][Full Text] [Related]
26. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018.
Wang X; Yang C; Jiang J; Hu Y; Hao Y; Dong JY
Front Public Health; 2023; 11():1116583. PubMed ID: 37033012
[TBL] [Abstract][Full Text] [Related]
27. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
Nishtala PS; Salahudeen MS
Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
[TBL] [Abstract][Full Text] [Related]
28. Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Bhagavathula AS; Tesfaye W; Vidyasagar K; Fialova D
Gerontology; 2022; 68(10):1081-1090. PubMed ID: 35026767
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H
Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438
[TBL] [Abstract][Full Text] [Related]
30. Low-Trauma Fracture Increases 12-Month Incidence of Cardiovascular Disease for Adults With Cerebral Palsy.
Whitney DG; Whitney RT; Prisby RD; Jepsen KJ
J Orthop Res; 2020 Apr; 38(4):803-810. PubMed ID: 31710380
[TBL] [Abstract][Full Text] [Related]
31. Association between polypharmacy and chronic kidney disease among community-dwelling older people: a longitudinal study in southern China.
Zhang B; Wang J; Liu N; Liu W; Xi R; Wang P
BMC Nephrol; 2024 May; 25(1):169. PubMed ID: 38760750
[TBL] [Abstract][Full Text] [Related]
32. Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease.
Burrows NR; Koyama AK; Choudhury D; Yu W; Pavkov ME; Nee R; Cheung AK; Norris KC; Yan G
Am J Nephrol; 2022; 53(8-9):652-662. PubMed ID: 36209732
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).
Kennel PJ; Kneifati-Hayek J; Bryan J; Banerjee S; Sobol I; Lachs MS; Safford MM; Goyal P
BMC Cardiovasc Disord; 2019 Apr; 19(1):76. PubMed ID: 30935411
[TBL] [Abstract][Full Text] [Related]
34. Elevated fracture risk for adults with neurodevelopmental disabilities.
Whitney DG; Caird MS; Jepsen KJ; Kamdar NS; Marsack-Topolewski CN; Hurvitz EA; Peterson MD
Bone; 2020 Jan; 130():115080. PubMed ID: 31655219
[TBL] [Abstract][Full Text] [Related]
35. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
36. Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults.
Si J; Yu C; Guo Y; Bian Z; Qin C; Yang L; Chen Y; Yin L; Li H; Lan J; Chen J; Chen Z; Lv J; Li L;
BMC Med; 2018 Jun; 16(1):93. PubMed ID: 29909773
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
38. Mortality and Resource Use Among Individuals With Chronic Kidney Disease or Cancer in Alberta, Canada, 2004-2015.
Tonelli M; Lloyd A; Cheung WY; Hemmelgarn BR; James MT; Ravani P; Manns B; Klarenbach SW
JAMA Netw Open; 2022 Jan; 5(1):e2144713. PubMed ID: 35076702
[TBL] [Abstract][Full Text] [Related]
39. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
Sutaria A; Liu L; Ahmed Z
Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
[TBL] [Abstract][Full Text] [Related]
40. Moderate to Severe Renal Insufficiency Is Associated With High Mortality After Hip and Knee Replacement.
Jämsä P; Jämsen E; Huhtala H; Eskelinen A; Oksala N
Clin Orthop Relat Res; 2018 Jun; 476(6):1284-1292. PubMed ID: 29601379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
